Legal Representation
Attorney
Kristen Mollnow Walsh
USPTO Deadlines
Next Deadline
128 days remaining
NOA E-Mailed - SOU Required
Due Date
April 29, 2026
Extension Available
Until October 29, 2026
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 6, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 9, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 2, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 1, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 28, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 24, 2025 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Apr 24, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Nov 5, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 18, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 10, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 5, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 17, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 17, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 17, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 8, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 8, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 8, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 8, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 8, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 7, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 7, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Enzymes, DNA vectors, viral vectors, rAAV vectors, and DNA extracts for the preparation of nucleic acid, for scientific and research purposes; enzymes for use in the preparation and creation of DNA extracts and DNA cassettes for scientific and industrial purposes; DNA vectors, viral vectors, rAAV vectors, and DNA extracts and DNA cassettes for scientific and research use; DNA vectors, viral vectors, rAAV vectors, DNA extracts for scientific and research purposes in the fields of agri-biotechnology and nanotechnology; Biological and biochemical reagents being DNA plasmid vectors, DNA vectors, and rAAV vectors, viral vectors that form a gene analysis system not for medical purposes; diagnostic reagents for scientific or research purposes, namely, a diagnostic kit consisting primarily of DNA vectors, rAAV vectors, and DNA plasmid vectors for scientific and research purposes
Class 005
Biotechnological products, namely, viral DNA vectors, DNA vectors, and rAAV vectors, for the delivery of genes and other materials, in the nature of DNA, RNA, and transcriptional targeting promoters, to a biological cell for medical purposes; biological preparations, namely, viral vectors, rAAV vectors, and DNA extracts for production of DNA vectors and viral vectors, for medical purposes
Additional Information
Pseudo Mark
ASK BIO
Classification
International Classes
001
005